These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15955662)

  • 1. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
    Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence.
    Yanagawa T; Yoshida H; Yamagata K; Onizawa K; Tabuchi K; Koyama Y; Iwasa S; Shimoyamada H; Harada H; Omura K
    J Exp Clin Cancer Res; 2007 Jun; 26(2):215-20. PubMed ID: 17725101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth.
    Kawano K; Yanagisawa S
    Head Neck; 2006 Jun; 28(6):525-33. PubMed ID: 16619276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
    Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
    Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of SPARC in clinical stage II tongue squamous cell carcinoma.
    Zhang J; Zhang Q; Zhang Q; Liu XK; Li CQ; Guo ZM
    Ai Zheng; 2009 Jan; 28(1):68-71. PubMed ID: 19448421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue.
    Huang CF; Sun ZJ; Zhao YF; Chen XM; Jia J; Zhang WF
    Oral Dis; 2011 Apr; 17(3):328-34. PubMed ID: 20796224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multivariate analysis of prognosis of patients with clinical stage I and II carcinoma of mobile tongue].
    Hua H; Zeng ZY; Xu GP
    Ai Zheng; 2003 Feb; 22(2):210-3. PubMed ID: 12600303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
    Park JH; Kim YS; Lee HL; Shim JY; Lee KS; Oh YJ; Shin SS; Choi YH; Park KJ; Park RW; Hwang SC
    Respirology; 2006 May; 11(3):269-75. PubMed ID: 16635084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein expression in the squamous cell carcinoma of the tongue base.
    Rabkin D; Chhieng DC; Miller MB; Jennings T; Feustel P; Steiniger J; Parnes SM
    Laryngoscope; 1995 Dec; 105(12 Pt 1):1294-9. PubMed ID: 8523980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cIAP-1 correlates with nodal metastasis in squamous cell carcinoma of the tongue.
    Qi S; Mogi S; Tsuda H; Tanaka Y; Kozaki K; Imoto I; Inazawa J; Hasegawa S; Omura K
    Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1047-53. PubMed ID: 18621506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
    Wang L; Liu T; Nishioka M; Aguirre RL; Win SS; Okada N
    Oral Oncol; 2006 Jul; 42(6):625-31. PubMed ID: 16483832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
    Kawano K; Yanagisawa S; Kusukawa J; Sunagawa H; Shiba R; Goto M; Shinohara M; Fukuda J; Oishi M; Ikemura K; Takahashi T; Sugihara K; Inokuchi T; Mimura T; Goto H
    Int J Oral Maxillofac Surg; 2006 Mar; 35(3):258-64. PubMed ID: 16280240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.
    Kurokawa A; Nagata M; Kitamura N; Noman AA; Ohnishi M; Ohyama T; Kobayashi T; Shingaki S; Takagi R;
    Cancer; 2008 Mar; 112(6):1272-81. PubMed ID: 18224668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt activation correlates with adverse outcome in tongue cancer.
    Massarelli E; Liu DD; Lee JJ; El-Naggar AK; Lo Muzio L; Staibano S; De Placido S; Myers JN; Papadimitrakopoulou VA
    Cancer; 2005 Dec; 104(11):2430-6. PubMed ID: 16245318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
    Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Ochiai T
    Oncol Rep; 2007 Oct; 18(4):867-71. PubMed ID: 17786348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.
    Matsuzaki H; Shima K; Muramatsu T; Ro Y; Hashimoto S; Shibahara T; Shimono M
    J Oral Pathol Med; 2007 Jan; 36(1):30-4. PubMed ID: 17181739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.